Natural history of Sanfilippo syndrome in Spain

Verónica Delgadillo1, Maria del Mar O'Callaghan, Laura Gort

  • 1Neuropediatrics Department, Hospital Sant Joan de Déu, Barcelona, Spain. vdelgadillo@hsjdbcn.org.

Abstract

Insights

Mucopolysaccharidosis type III (MPS III), or Sanfilippo syndrome, is a rare genetic disorder. This study highlights MPS IIIA as the most common subtype in Spain, emphasizing early diagnosis for better patient outcomes.

Area of Science:

  • Genetics and rare diseases
  • Lysosomal storage disorders
  • Biochemistry of heparan sulfate degradation

Background:

  • Mucopolysaccharidosis type III (MPS III), or Sanfilippo syndrome, results from deficiencies in four key enzymes for heparan sulfate lysosomal degradation.
  • MPS III exhibits significant phenotypic heterogeneity across its four recognized types.
  • This study provides the first description of the natural history of Sanfilippo syndrome in Spain, covering MPS IIIA, MPS IIIB, and MPS IIIC.

Purpose of the Study:

  • To establish the natural history of MPS III in a Spanish cohort.
  • To understand patient prognosis and inform the development of future therapies.
  • To analyze clinical, biochemical, and molecular data for Spanish MPS III patients.

Main Methods:

  • Retrospective study design.
  • Extensive chronological data collection from physicians and parents of 55 Spanish MPS III patients.
  • Inclusion of clinical descriptions, biochemical, and molecular analyses.

Main Results:

  • MPS IIIA was the most frequent subtype (62%).
  • Common early symptoms included speech delay (85%), coarse facial features (78%), and hyperactivity (65%) around age 3.
  • Median diagnosis ages were 4.4 years (IIIA), 3.1 years (IIIB), and 6.3 years (IIIC). Epilepsy developed in 45% of patients around age 8.7.
  • Molecular analysis showed significant allelic heterogeneity without clear genotype-phenotype correlations.

Conclusions:

  • MPS IIIA is the predominant subtype among Spanish Sanfilippo patients.
  • Physicians should suspect Sanfilippo syndrome in children presenting with non-specific speech delay, behavioral issues, or mild dysmorphic features.
  • Early diagnosis is crucial for implementing timely enzymatic or gene therapies to improve patient prognosis.

Related Concept Videos

Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
1.1K
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.5K
Huntington Disease l: Introduction01:21

Huntington Disease l: Introduction

Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show...
110
iPS Cell Differentiation01:22

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.2K
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
121
Sex-linked Disorders01:43

Sex-linked Disorders

Like autosomes, sex chromosomes contain a variety of genes necessary for normal body function. When a mutation in one of these genes results in biological deficits, the disorder is considered sex-linked.
94.4K